Hemodialysis: the far side of the moon
Frontiers in Kidney Medicine & Biology's podcast
Release Date: 01/26/2022
CONVINCE Study
Frontiers in Kidney Medicine & Biology's podcast
In this episode of #Frontiers in Kidney Medicine and Biology, Dr. Peter Blankestijn from the Department of Nephrology at the University Medical Center, Utrecht; Krister Cromm, Expert Director of Patient Experience and Clinical Research at Fresenius Medical Care; and Dr. Sandip Mitra, Consultant Nephrologist and Honorary Lecturer at the University of Manchester, join Dr. Peter Kotanko, Head of Biomedical Evidence Generation and the Renal Research Institute, to talk about the groundbreaking CONVINCE Study and the impressive results that came from it. Learn how this study came to fruition and its...
info_outline
Peritoneal Dialysis Accessibility
Frontiers in Kidney Medicine & Biology's podcast
The Renal Research Institute is excited to be back with #Frontiers in Kidney Medicine and Biology, where Dr. Peter Kotanko, Head of Biomedical Evidence Generation and the Renal Research Institute, discusses and shares the latest knowledge and advances in kidney research. In this episode, Dr. Edwina Brown, Consultant Nephrologist and President of the International Society of Peritoneal Dialysis (ISPD) sits down with Dr. Kotanko to talk about her goals as president of the ISPD and her plans to make peritoneal dialysis more accessible to low- and middle- income countries.
info_outline
Solutes, Scaling, Sex: are we getting the dosing of dialysis, right?
Frontiers in Kidney Medicine & Biology's podcast
Join Dr. Peter Kotanko, MD, FASN, Head of Biomedical Evidence Generation and Renal Research Institute, and John Daugirdas, MD, FACP, FASN, Clinical Professor of Medicine at the University of Illinois School of Medicine at Chicago, as they discuss aspects of dialysis patient prescription.
info_outline
Aging across the animal kingdom: lessons for humanity?
Frontiers in Kidney Medicine & Biology's podcast
Join Dr. Peter Kotanko, MD, FASN, Head of Biomedical Evidence Generation and Renal Research Institute, and Peter Stenvinkel, MD, PhD, Professor of Renal Medicine at Karolinska Institutet they discuss the principles of early vascular aging in chronic kidney disease. We will also discuss what we can learn from the animal kingdom in order to identify novel opportunities to slow down the aging process in humans with the burden of lifestyle diseases. We will also discuss the role of and identification of biomarkers of biological age.
info_outline
What ECG can tell us about the events on molecular scale
Frontiers in Kidney Medicine & Biology's podcast
Join Dr. Peter Kotanko, MD, FASN Head of Biomedical Evidence Generation and Renal Research Institute, and Axel Loewe, PhD, Group Leader "Computational Cardiac Modeling" at Karlsruhe Institute of Technology (KIT) as they discuss the opportunities that the electrocardiogram (ECG) offers for the detection of electrolyte imbalances. The advantages of the ECG and the current state of the art of manual and automatic algorithms are summarized. A particular field of interest is the use of machine learning methods for an automatic classification or regression of electrolyte imbalances and...
info_outline
Hemodialysis: the far side of the moon
Frontiers in Kidney Medicine & Biology's podcast
Join Drs. Peter Kotanko from the Renal Research Institute and Nicholas Selby from the University of Nottingham for their discussion about hemodialysis, one of the main treatments for kidney failure, but also a treatment that can have adverse consequences. Some of these relate to the 'stress' that dialysis can exert on the cardiovascular system, which in turn affects the delivery of blood to different organs. We will discuss how this happens, what it means for patients, and what can be done to address this.
info_outline
Kidney disease in our changing world: challenges and opportunities
Frontiers in Kidney Medicine & Biology's podcast
In this episode, Dr. Peter Kotanko, MD FASN, Research Director from Renal Research Institute is joined by Drs. Valerie Luyckx, MBBCh, MSc, PhD from Children's Hospital in Zurich, Switzerland & Marcello Tonelli, MD, SM, FRCPC from the University of Calgary, as they discuss the intersection between kidney medicine and the United Nations Sustainable Development Goals.
info_outline
COVID, chaos, computation: what mathematics can tell us about pandemics
Frontiers in Kidney Medicine & Biology's podcast
In this episode of Frontiers In Kidney Medicine & Biology, Dr. Peter Kotanko, Research Director at Renal Research Institute (RRI) is joined by Dr. Alhaji Cherif, PhD, Principal Mathematician also from RRI as they discuss the use of mathematical modeling and computations to gain insights into the pandemic in order to provide effective intervention measures and to understand the drivers of the contagion among kidney patients.
info_outline
Pervasive sensing, privacy and patient care: a glimpse into the future
Frontiers in Kidney Medicine & Biology's podcast
In this episode of Frontiers in Kidney Medicine & Biology, Dr. Peter Kotanko, Research Director at Renal Research Institute is joined by Dr. Fokko Pieter Wieringa, PhD, Principal Scientist at IMEC in The Netherlands as they address what pervasive sensing is (including some examples), as well as go into the opportunities and risk of pervasive sensing. If time allows, we will discuss in what direction pervasive sensing may be going.
info_outline
A fresh look at an old problem: renal anemia
Frontiers in Kidney Medicine & Biology's podcast
In this episode, Dr. Peter Kotanko is joined by Dr. Roberto Pecoit-Filho, Senior Research Scientist from the Arbor Research Collaborative for Health, to discuss the differences between anemia in the general population and in patients with kidney disease. We also discuss the current understanding of the mechanisms behind CKD anemia and the perspective of the introduction of new treatment options and an expansion in the understanding of the pathophysiology.
info_outlineJoin Drs. Peter Kotanko from the Renal Research Institute and Nicholas Selby from the University of Nottingham for their discussion about hemodialysis, one of the main treatments for kidney failure, but also a treatment that can have adverse consequences. Some of these relate to the 'stress' that dialysis can exert on the cardiovascular system, which in turn affects the delivery of blood to different organs. We will discuss how this happens, what it means for patients, and what can be done to address this.